Rosuvastatin (20 mg) and Fenofibrate (160 mg)

Rosuvastatin (20 mg) and Fenofibrate (160 mg) 
ROUSTRIN F is a combination medication that is used for the treatment of dyslipidemia, a condition characterized by abnormal levels of lipids (cholesterol and triglycerides) in the blood. Each medication works through different mechanisms to help improve lipid profiles and reduce the risk of cardiovascular disease.
Rosuvastatin reduces the production of cholesterol in the liver and increases the liver's ability to remove LDL (low-density lipoprotein) cholesterol from the bloodstream. It is particularly effective in lowering LDL cholesterol levels and has also shown benefits in increasing HDL (high-density lipoprotein) cholesterol, often referred to as "good" cholesterol.
Fenofibrate works by activating the peroxisome proliferator-activated receptor-alpha (PPAR-alpha). This activation leads to an increase in the activity of lipoprotein lipase, an enzyme responsible for breaking down triglycerides. As a result, fenofibrate helps to lower triglyceride levels in the blood while also increasing HDL cholesterol levels.
Both ingredients in ROUSTRIN F complement each other's effects, targeting different aspects of dyslipidemia.
STERIS PHARMA deals in Generic medicines that  promotes healthy competition in the pharmaceutical industry, which can help to drive down prices and improve overall affordability.
For further information
please contact: info@sterispharma.com
Order now:
https://www.sterisonline.com/product/roustrin-f-20-133367